Granulomatous Infectious Diseases Associated with Tumor Necrosis Factor Antagonists

R. S. Wallis; M. S. Broder; J. Y. Wong; M. E. Hanson; D. O. Beenhouwer

doi:10.1086/383317

Granulomatous Infectious Diseases Associated with Tumor Necrosis Factor Antagonists

Clinical Infectious Diseases ◽

10.1086/383317 ◽

2004 ◽

Vol 38 (9) ◽

pp. 1261-1265 ◽

Cited By ~ 648

Author(s):

R. S. Wallis ◽

M. S. Broder ◽

J. Y. Wong ◽

M. E. Hanson ◽

D. O. Beenhouwer

Keyword(s):

Tumor Necrosis Factor ◽

Infectious Diseases ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Antagonists ◽

Necrosis Factor

Download Full-text

Faculty Opinions recommendation of A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1160775.622184 ◽

2009 ◽

Author(s):

Cyrus Tamboli

Keyword(s):

Tumor Necrosis Factor ◽

Drug Administration ◽

Safety Assessment ◽

Tumor Necrosis ◽

Food And Drug Administration ◽

Tumor Necrosis Factor Antagonists ◽

Necrosis Factor

Download Full-text

Faculty Opinions recommendation of Efficacy of vedolizumab induction and maintenance therapy in patients with ulcerative colitis, regardless of prior exposure to tumor necrosis factor antagonists.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.726749172.793568149 ◽

2019 ◽

Author(s):

Ashish Patel

Keyword(s):

Ulcerative Colitis ◽

Tumor Necrosis Factor ◽

Maintenance Therapy ◽

Tumor Necrosis ◽

Prior Exposure ◽

Tumor Necrosis Factor Antagonists ◽

Necrosis Factor

Download Full-text

Faculty Opinions recommendation of Association between use of thiopurines or tumor necrosis factor antagonists alone or in combination and risk of lymphoma in patients with inflammatory bowel disease.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.732092122.793568144 ◽

2019 ◽

Author(s):

Ashish Patel

Keyword(s):

Inflammatory Bowel Disease ◽

Tumor Necrosis Factor ◽

Bowel Disease ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Antagonists ◽

Inflammatory Bowel ◽

Necrosis Factor

Download Full-text

Tumor necrosis factor in the pathogenesis of infectious diseases

Critical Care Medicine ◽

10.1097/00003246-199310001-00003 ◽

1993 ◽

Vol 21 (Supplement) ◽

pp. S436 ◽

Cited By ~ 127

Author(s):

BRUCE BEUTLER ◽

GEORGES E. GRAU

Keyword(s):

Tumor Necrosis Factor ◽

Infectious Diseases ◽

Tumor Necrosis ◽

Necrosis Factor

Download Full-text

P154 PRIMARY NON-RESPONSE TO TUMOR NECROSIS FACTOR ANTAGONISTS IS ASSOCIATED WITH INFERIOR RESPONSE TO SECOND-LINE BIOLOGICS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A SYSTEMATIC REVIEW AND META-ANALYSIS

Gastroenterology ◽

10.1053/j.gastro.2017.11.204 ◽

2018 ◽

Vol 154 (1) ◽

pp. S81-S82

Author(s):

Siddharth Singh ◽

John George ◽

Brigid S. Boland ◽

Niels Vande Casteele ◽

William J. Sandborn

Keyword(s):

Systematic Review ◽

Tumor Necrosis Factor ◽

Inflammatory Bowel Diseases ◽

Tumor Necrosis ◽

Meta Analysis ◽

Second Line ◽

Tumor Necrosis Factor Antagonists ◽

Bowel Diseases ◽

Inflammatory Bowel ◽

Necrosis Factor

Download Full-text

Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists

Clinical Gastroenterology and Hepatology ◽

10.1016/j.cgh.2016.08.044 ◽

2017 ◽

Vol 15 (2) ◽

pp. 229-239.e5 ◽

Cited By ~ 74

Author(s):

Brian G. Feagan ◽

David T. Rubin ◽

Silvio Danese ◽

Severine Vermeire ◽

Brihad Abhyankar ◽

...

Keyword(s):

Ulcerative Colitis ◽

Tumor Necrosis Factor ◽

Maintenance Therapy ◽

Tumor Necrosis ◽

Prior Exposure ◽

Tumor Necrosis Factor Antagonists ◽

Necrosis Factor

Download Full-text

Treatment with Tumor Necrosis Factor Antagonists and Their Possible Effects on Morbidity and Mortality in Psoriasis Patients

Psoriasis Forum ◽

10.1177/247553031117a00106 ◽

2011 ◽

Vol 17a (1) ◽

pp. 56-62

Author(s):

Margarita Carlos ◽

Melanie Ortleb

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Morbidity And Mortality ◽

Tumor Necrosis Factor Antagonists ◽

Necrosis Factor

Download Full-text

655 Tumor Necrosis Factor Antagonists Are Superior to Ustekinumab and Vedolizumab for the Prevention of Postoperative Recurrence in Adult Crohn's Disease

The American Journal of Gastroenterology ◽

10.14309/01.ajg.0000592156.21664.71 ◽

2019 ◽

Vol 114 (1) ◽

pp. S384-S384

Author(s):

Takahiro Nakamura ◽

Michael Main ◽

Shannon Chang ◽

Benjamin Click ◽

David Hudesman ◽

...

Keyword(s):

Crohn’S Disease ◽

Tumor Necrosis Factor ◽

Crohn's Disease ◽

Tumor Necrosis ◽

Postoperative Recurrence ◽

Tumor Necrosis Factor Antagonists ◽

Necrosis Factor

Download Full-text

Distinct mechanisms of action of tumor necrosis factor antagonists: What are the clinical implications?

Seminars in Arthritis and Rheumatism ◽

10.1016/j.semarthrit.2005.01.001 ◽

2005 ◽

Vol 34 (5) ◽

pp. 1-2 ◽

Cited By ~ 3

Author(s):

William F.C. Rigby

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Mechanisms Of Action ◽

Clinical Implications ◽

Tumor Necrosis Factor Antagonists ◽

Necrosis Factor

Download Full-text

Exam 1: Efficacy and Safety of Tumor Necrosis Factor Antagonists in Treatment of Internal Fistulizing Crohn's Disease

Clinical Gastroenterology and Hepatology ◽

10.1016/j.cgh.2020.01.005 ◽

2020 ◽

Vol 18 (3) ◽

pp. e37-e38

Keyword(s):

Crohn’S Disease ◽

Tumor Necrosis Factor ◽

Crohn's Disease ◽

Tumor Necrosis ◽

Efficacy And Safety ◽

Tumor Necrosis Factor Antagonists ◽

Necrosis Factor

Download Full-text